Latest Carlyle Group Inc. Stock Portfolio
Carlyle Group Inc. Performance:
2025 Q4: 2.38%YTD: -90.61%2024: -25.21%
Performance for 2025 Q4 is 2.38%, and YTD is -90.61%, and 2024 is -25.21%.
About Carlyle Group Inc. and 13F Hedge Fund Stock Holdings
On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Carlyle Group Inc. reported an equity portfolio of $13.6 Billions as of 31 Dec, 2025.
The top stock holdings of Carlyle Group Inc. are , , PHAT. The fund has invested 66.7% of it's portfolio in MEDLINE INC and 32.3% of portfolio in STANDARDAERO INC.
The fund managers got completely rid off ADICET BIO INC (ACET) stocks. They significantly reduced their stock positions in SPRUCE BIOSCIENCES INC (SPRB), EXICURE INC (XCUR) and SUNPOWER INC. Carlyle Group Inc. opened new stock positions in MEDLINE INC, ADICET BIO INC (ACET) and ROBINHOOD MKTS INC (HOOD). The fund showed a lot of confidence in some stocks as they added substantially to INVITATION HOMES INC (INVH).
The top stock holdings of Carlyle Group Inc. are , , PHAT. The fund has invested 66.7% of it's portfolio in MEDLINE INC and 32.3% of portfolio in STANDARDAERO INC.
The fund managers got completely rid off ADICET BIO INC (ACET) stocks. They significantly reduced their stock positions in SPRUCE BIOSCIENCES INC (SPRB), EXICURE INC (XCUR) and SUNPOWER INC. Carlyle Group Inc. opened new stock positions in MEDLINE INC, ADICET BIO INC (ACET) and ROBINHOOD MKTS INC (HOOD). The fund showed a lot of confidence in some stocks as they added substantially to INVITATION HOMES INC (INVH).
Carlyle Group Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Carlyle Group Inc. made a return of 2.38% in the last quarter. In trailing 12 months, it's portfolio return was -90.61%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| medline inc | 9,042,730,000 |
| adicet bio inc | 1,544,390 |
| robinhood mkts inc | 381,826 |
| spyre therapeutics inc | 315,055 |
New stocks bought by Carlyle Group Inc.
Additions
| Ticker | % Inc. |
|---|---|
| invitation homes inc | 39.08 |
Additions to existing portfolio by Carlyle Group Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| spruce biosciences inc | -98.67 |
| exicure inc | -80.00 |
| sunpower inc | -65.59 |
Carlyle Group Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| adicet bio inc | -2,388,760 |
Carlyle Group Inc. got rid off the above stocks
Sector Distribution
Carlyle Group Inc. has about 99.2% of it's holdings in Others sector.
- Others
| Sector | % |
|---|---|
| Others | 99.2 |
Market Cap. Distribution
Carlyle Group Inc. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
| Category | % |
|---|---|
| UNALLOCATED | 99.2 |
Stocks belong to which Index?
About 0% of the stocks held by Carlyle Group Inc. either belong to S&P 500 or RUSSELL 2000 index.
- Others
| Index | % |
|---|---|
| Others | 99.4 |
Carlyle Group Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Carlyle Group Inc.
Carlyle Group Inc. has 20 stocks in it's portfolio. About 99.9% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Carlyle Group Inc. last quarter.
Last Reported on: 13 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 0.01 | 184,295 | 1,544,390 | new | |||
| ACET | adicet bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 0.00 | 9,620 | 315,055 | new | |||
| CUBE | cubesmart | 0.06 | 220,500 | 7,949,020 | unchanged | 0.00 | ||
| DNUT | krispy kreme inc | 0.01 | 340,748 | 1,369,810 | unchanged | 0.00 | ||
| GETY | getty images holdings inc | 0.06 | 6,234,250 | 8,353,900 | unchanged | 0.00 | ||
| HOOD | robinhood mkts inc | 0.00 | 3,376 | 381,826 | new | |||
| INVH | invitation homes inc | 0.14 | 664,100 | 18,455,300 | added | 39.08 | ||
| JSPR | jasper therapeutics inc | 0.01 | 1,066,190 | 1,940,460 | unchanged | 0.00 | ||
| NABL | n-able inc | 0.00 | 93,732 | 701,115 | unchanged | 0.00 | ||
| NCNA | nucana plc | 0.00 | 133,333 | 479,999 | unchanged | 0.00 | ||
| PHAT | phathom pharmaceuticals inc | 0.43 | 3,496,810 | 57,977,100 | unchanged | 0.00 | ||
| SPRB | spruce biosciences inc | 0.02 | 38,620 | 3,298,920 | reduced | -98.67 | ||
| XCUR | exicure inc | 0.00 | 56,328 | 304,734 | reduced | -80.00 | ||
| medline inc | 66.65 | 215,303,000 | 9,042,730,000 | new | ||||
| standardaero inc | 32.27 | 152,674,000 | 4,378,690,000 | unchanged | 0.00 | |||
| pony ai inc | 0.25 | 2,362,450 | 34,255,500 | unchanged | 0.00 | |||
| q32 bio inc | 0.03 | 1,102,740 | 3,616,990 | unchanged | 0.00 | |||
| forward air corp | 0.02 | 107,214 | 3,093,610 | unchanged | 0.00 | |||
| onkure therapeutics inc | 0.01 | 269,895 | 771,900 | unchanged | 0.00 | |||